DK0948630T3 - Kloning og karakterisering af napsin, en asparaginprotease - Google Patents

Kloning og karakterisering af napsin, en asparaginprotease

Info

Publication number
DK0948630T3
DK0948630T3 DK97948546T DK97948546T DK0948630T3 DK 0948630 T3 DK0948630 T3 DK 0948630T3 DK 97948546 T DK97948546 T DK 97948546T DK 97948546 T DK97948546 T DK 97948546T DK 0948630 T3 DK0948630 T3 DK 0948630T3
Authority
DK
Denmark
Prior art keywords
napsin
enzyme
protease
cloned
expressed
Prior art date
Application number
DK97948546T
Other languages
Danish (da)
English (en)
Inventor
Xinli Lin
Jordan J N Tang
Gerald Koelsch
Original Assignee
Oklahoma Med Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oklahoma Med Res Found filed Critical Oklahoma Med Res Found
Application granted granted Critical
Publication of DK0948630T3 publication Critical patent/DK0948630T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6478—Aspartic endopeptidases (3.4.23)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
DK97948546T 1996-11-20 1997-11-20 Kloning og karakterisering af napsin, en asparaginprotease DK0948630T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3119696P 1996-11-20 1996-11-20
US4612697P 1997-05-09 1997-05-09
PCT/US1997/021684 WO1998022597A2 (en) 1996-11-20 1997-11-20 Cloning and characterization of napsin, an aspartic protease

Publications (1)

Publication Number Publication Date
DK0948630T3 true DK0948630T3 (da) 2008-08-11

Family

ID=26706937

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97948546T DK0948630T3 (da) 1996-11-20 1997-11-20 Kloning og karakterisering af napsin, en asparaginprotease

Country Status (11)

Country Link
US (1) US6225103B1 (de)
EP (1) EP0948630B1 (de)
JP (2) JP2001503643A (de)
AT (1) ATE393227T1 (de)
AU (1) AU734220B2 (de)
CA (1) CA2271294A1 (de)
DE (1) DE69738653T2 (de)
DK (1) DK0948630T3 (de)
ES (1) ES2308791T3 (de)
PT (1) PT948630E (de)
WO (1) WO1998022597A2 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0897986A3 (de) * 1997-08-21 2000-07-05 Smithkline Beecham Corporation Aspartat proteinase 5 (ASP5)
US6203979B1 (en) 1998-01-16 2001-03-20 Incyte Pharmaceuticals, Inc. Human protease molecules
US6432690B1 (en) * 1998-01-16 2002-08-13 Incyte Genomics, Inc. Human aspartic proteases
US7045333B1 (en) 1998-01-16 2006-05-16 Incyte Corporation Human protease molecules
WO2000004137A1 (en) * 1998-07-16 2000-01-27 Incyte Pharmaceuticals, Inc. Human aspartic proteases
EP1939297A1 (de) 1998-09-24 2008-07-02 Pharmacia & Upjohn Company LLC Alzheimerkrankheit-Sekretase
US7115410B1 (en) 1999-02-10 2006-10-03 Elan Pharmaceuticals, Inc. β-secretase enzyme compositions and methods
US7456007B1 (en) 1998-12-31 2008-11-25 Elan Pharmaceuticals, Inc. β-secretase enzyme compositions and methods
JP4653318B2 (ja) 1999-02-10 2011-03-16 エラン ファーマシューティカルズ，インコーポレイテッド βセクレターゼ酵素組成物および方法
US7514408B1 (en) 1999-12-02 2009-04-07 Elan Pharmaceuticals, Inc. β-secretase enzyme compositions and methods
JP2001172200A (ja) * 1999-12-17 2001-06-26 Meneki Seibutsu Kenkyusho:Kk ヒトナプシンａに対する抗体およびこれを用いる医薬
WO2002000891A2 (en) * 2000-06-26 2002-01-03 Bayer Aktiengesellschaft Human napsin-like aspartyl protease
PE20020276A1 (es) 2000-06-30 2002-04-06 Elan Pharm Inc COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
EP1666452A2 (de) 2000-06-30 2006-06-07 Elan Pharmaceuticals, Inc. Verbindungen zur Behandlung der Alzheimerischen Krankheit
EP1500663A1 (de) * 2000-09-28 2005-01-26 Eli Lilly And Company Sekretierte proteine und ihre Verwendungen
US7601528B1 (en) 2000-12-23 2009-10-13 Elan Pharmaceuticals, Inc. Crystallization and structure determination of glycosylated human beta secretase, an enzyme implicated in alzheimer's disease
US7217556B1 (en) 2000-12-23 2007-05-15 Pfizer Inc Crystallization and structure determination of glycosylated human beta secretase, an enzyme implicated in Alzheimer's disease
US7806980B2 (en) * 2000-12-23 2010-10-05 Elan Pharmaceuticals, Inc. Method for crystallizing human beta secretase in complex with an inhibitor
US7524668B1 (en) * 2001-05-10 2009-04-28 Elan Pharmaceuticals, Inc. Crystal of human beta secretase having monoclinic space group symmetry C2 and methods for crystallization thereof
US7384773B1 (en) * 2001-05-10 2008-06-10 Pfizer Inc Crystal of HIV protease-cleaved human beta secretase and method for crystallization thereof
US7144897B2 (en) 2001-06-01 2006-12-05 Elan Oharmaceuticals, Inc. Hydroxy alkyl amines
MXPA03011521A (es) 2001-06-13 2004-03-18 Elan Pharm Inc Aminadioles para tratamiento de enfermedad de alzheimer.
MXPA04000338A (es) 2001-07-10 2004-07-23 Upjohn Co Diamindioles para tratamiento de enfermedad de alzheimer.
JP2005505517A (ja) 2001-07-10 2005-02-24 イーラン ファーマスーティカルズ、インコーポレイテッド アルツハイマー病を治療するためのアミンジオール
US7186539B1 (en) 2001-08-31 2007-03-06 Pharmacia & Upjohn Company Method for refolding enzymes
CA2462851A1 (en) 2001-10-04 2003-04-10 Elan Pharmaceuticals, Inc. Hydroxypropylamines
KR20050044407A (ko) 2001-11-08 2005-05-12 엘란 파마슈티칼스, 인크. N,n'-치환-1,3-디아미노-2-히드록시프로판 유도체
EP1572904B1 (de) 2002-02-21 2009-04-15 Pharmacia & Upjohn Company LLC Modifizierte bace
US7262208B2 (en) 2002-04-30 2007-08-28 Elan Pharmaceuticals, Inc. Hydroxypropyl amides for the treatment of Alzheimer's disease
US7442537B1 (en) 2002-05-10 2008-10-28 Elan Pharmaceuticals, Inc. Crystals of unliganded beta secretase and/or beta secretase-like proteins and the use thereof
AU2003268023A1 (en) * 2002-07-23 2004-02-09 Incyte Corporation Protein modification and maintenance molecules
US7351738B2 (en) 2002-11-27 2008-04-01 Elan Pharmaceuticals, Inc. Substituted ureas and carbamates
BRPI0409624A (pt) 2003-04-21 2006-04-18 Elan Pharm Inc 2-hidróxi-3-diaminoalcanos de benzamida
WO2004099402A1 (en) 2003-05-02 2004-11-18 Elan Pharmaceuticals, Inc. Glycosylation variants of bace
WO2005044977A2 (en) * 2003-06-25 2005-05-19 Diadexus, Inc. Compositions, splice variants and methods relating to lung specific genes and proteins
CA2558034A1 (en) 2004-03-09 2005-09-22 Elan Pharmaceuticals, Inc. Substituted hydroxyethylamine aspartyl protease inhibitors
US20070292346A1 (en) * 2004-03-25 2007-12-20 Rong Fan Lng105 Antibody Composition and Methods of Use, and Use of Lng105 to Assess Lung Cancer Risk
WO2006010095A2 (en) 2004-07-09 2006-01-26 Elan Pharmaceuticals Inc. Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
WO2007047305A1 (en) 2005-10-12 2007-04-26 Elan Pharmaceuticals, Inc. Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors
JP5450407B2 (ja) 2007-07-06 2014-03-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 置換アミノ−キナゾリノン、前記化合物を含む薬物、それらの使用及び製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL107250A (en) * 1993-10-12 2001-08-08 Yeda Res & Dev Dna molecules involved in programmed cell death, proteins encoded thereby and methods and compositions using said dna molecules and proteins
GB9618966D0 (en) * 1996-09-11 1996-10-23 Smithkline Beecham Plc Novel compounds
US5776759A (en) * 1996-09-26 1998-07-07 Incyte Pharmaceuticals, Inc. Two novel human cathepsin proteins

Also Published As

Publication number Publication date
JP2008118996A (ja) 2008-05-29
AU5459298A (en) 1998-06-10
US6225103B1 (en) 2001-05-01
ES2308791T3 (es) 2008-12-01
AU734220B2 (en) 2001-06-07
EP0948630B1 (de) 2008-04-23
WO1998022597A2 (en) 1998-05-28
JP2001503643A (ja) 2001-03-21
CA2271294A1 (en) 1998-05-28
DE69738653D1 (de) 2008-06-05
WO1998022597A3 (en) 1998-07-09
EP0948630A2 (de) 1999-10-13
ATE393227T1 (de) 2008-05-15
DE69738653T2 (de) 2009-06-04
PT948630E (pt) 2008-06-11

Similar Documents

Publication Publication Date Title
DK0948630T3 (da) Kloning og karakterisering af napsin, en asparaginprotease
Collier et al. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen.
Christensson et al. Complex formation between protein C inhibitor and prostate‐specific antigen in vitro and in human semen
Nishiura et al. The occurrence of an inhibitor of Ca2+-dependent neutral protease in rat liver
Shimamoto et al. Partial characterization of an enzyme fraction with protease activity which converts the spore peptidoglycan hydrolase (SleC) precursor to an active enzyme during germination of Clostridium perfringens S40 spores and analysis of a gene cluster involved in the activity
WO1998022597A9 (en) Cloning and characterization of napsin, an aspartic protease
Cao et al. Identification of a myofibril-bound serine proteinase (MBSP) in the skeletal muscle of lizard fish Saurida wanieso which specifically cleaves the arginine site
NO923469L (no) Chymotrypsin-lignende proteaser og deres inhibitorer
Ohara et al. Cloning, nucleotide sequence, and expression of Achromobacter protease I gene
TAKEDA et al. Isolation, and catalytic and immunochemical properties of cathepsin D-like acid proteinase from rat erythrocytes
Nagano et al. Molecular cloning and characterization of a serine proteinase gene of Trichinella spiralis
Nomura et al. Sea urchin hatching enzyme (envelysin): cDNA cloning and deprivation of protein substrate specificity by autolytic degradation
AU739546B2 (en) Forms of prostate specific antigen and methods for their detection
Yamauchi et al. Recombinant and native zymogen forms of human complement factor D.
Takahashi et al. Purification and characterization of porcine kidney cathepsin B
US4923818A (en) DNA clone of human type IV collagenase
CZ417897A3 (cs) Lidský žlázový kallikrein-1 (hk2)
Olalla et al. Purification and properties of three proteases from the larvae of the brine shrimp Artemia salina
CA1339874C (en) Dna clone of human type iv collagenase
JP2001503991A (ja) 転移性前立腺癌の検出方法
Prescott et al. [32] Leucostoma peptidase A
JP4177253B2 (ja) 細胞死抑制活性を有するペプチド断片を調製する方法
Mason et al. Baculoviral expression and characterization of rodent cathepsin S
Baker et al. Purification and partial characterization of rat factor D
AU2008202374B2 (en) Genetically modified ecarin and process for producing the same